Relyvrio ALS Drug Withdrawn by Manufacturer Due to Lack of Efficacy Due to FDA concerns about its efficacy, Relyvrio, an ALS medication, was removed from the market by Amylyx Pharmaceuticals. by Quincy Jon
Health Brushstrokes In Paintings Can Predict Onset Of Neurodegenerative Diseases Like Alzheimer's by Allan Adamson
Healthy Living/Wellness Two-Fifths Of Parkinson's Patients Hide Symptoms, Diagnosis: Survey by Angela Laguipo
Healthy Living/Wellness New Implantable Capsule Releases Antibodies To Help Fight Alzheimer's Disease by Alyssa Navarro
Healthy Living/Wellness Toxin From Algae Blooms May Cause Alzheimer's, Other Diseases by Katrina Pascual
Healthy Living/Wellness Stem Cell Therapy For Parkinson's Disease Gets Approval For Human Testing by Alyssa Navarro
Healthy Living/Wellness Julianna Snow: Psychiatrist Says Children Below 5 Years Old Do Not Understand Death by Julienne Roman
Healthy Living/Wellness Parents Allow 5-Year-Old Terminally Ill Daughter To Choose 'Heaven Or Hospital' by Angela Laguipo
Healthy Living/Wellness Over 46 Million Suffer From Dementia, Number To Increase To 131.5 Million By 2050: World Alzheimer Report by Alyssa Navarro
Healthy Living/Wellness Feeling Dizzy After Standing May Hint Serious Health Problem, Higher Risks For Early Death by Julienne Roman
Healthy Living/Wellness Alzheimer's Could Be Transmissible: How It Happens And How To Prevent It by Rina Marie Doctor
Healthy Living/Wellness People Suffering From Gout Less Likely To Develop Alzheimer's: Study by Sumit Passary
Healthy Living/Wellness Amino Acids in Protein Can Be Assembled Without DNA and mRNA: Study by Rhodi Lee
Healthy Living/Wellness Transforming thought into action: Accenture, Philips announce wearable tech for neurodegenerative patients by Linda Nguyen